Get the Stockscreener App
72.10
1.84%
-1.35
After Hours:
71.91
-0.19
-0.26%
Inspire Medical Systems Inc stock is traded at $72.10, with a volume of 1.03M.
It is down -1.84% in the last 24 hours and down -21.86% over the past month.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
See More
Previous Close:
$73.45
Open:
$73.5
24h Volume:
1.03M
Relative Volume:
0.65
Market Cap:
$2.09B
Revenue:
$861.31M
Net Income/Loss:
$53.12M
P/E Ratio:
41.77
EPS:
1.7262
Net Cash Flow:
$85.01M
1W Performance:
-11.85%
1M Performance:
-21.86%
6M Performance:
-42.82%
1Y Performance:
-62.44%
1-Day Range:
$71.21
$74.18
1-Week Range:
$71.21
$84.24
52-Week Range:
$70.77
$203.12
Inspire Medical Systems Inc Stock (INSP) Company Profile
Name
Inspire Medical Systems Inc
Sector
Industry
Phone
763-957-5037
Address
5500 WAYZATA BLVD, GOLDEN VALLEY
Compare INSP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INSP
Inspire Medical Systems Inc
|
72.10 | 2.13B | 861.31M | 53.12M | 85.01M | 1.7262 |
|
ABT
Abbott Laboratories
|
109.02 | 190.25B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
360.82 | 140.79B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
BSX
Boston Scientific Corp
|
91.62 | 136.25B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
MDT
Medtronic Plc
|
103.18 | 131.68B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
82.10 | 47.96B | 5.88B | 1.34B | 799.60M | 2.3489 |
Inspire Medical Systems Inc Stock (INSP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-27-26 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jan-22-26 | Downgrade | Oppenheimer | Outperform → Perform |
| Jan-22-26 | Downgrade | Truist | Buy → Hold |
| Dec-08-25 | Upgrade | Oppenheimer | Perform → Outperform |
| Dec-02-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-26-25 | Upgrade | Truist | Hold → Buy |
| Nov-25-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Nov-24-25 | Upgrade | Stifel | Hold → Buy |
| Nov-04-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-24-25 | Downgrade | Jefferies | Buy → Hold |
| Sep-22-25 | Downgrade | UBS | Buy → Neutral |
| Sep-02-25 | Initiated | Evercore ISI | Outperform |
| Aug-05-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-05-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Aug-05-25 | Downgrade | Truist | Buy → Hold |
| Nov-20-24 | Upgrade | BofA Securities | Neutral → Buy |
| May-08-24 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-19-24 | Initiated | RBC Capital Mkts | Outperform |
| Mar-19-24 | Initiated | Morgan Stanley | Overweight |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Overweight |
| Jan-19-24 | Initiated | Jefferies | Buy |
| Jan-02-24 | Downgrade | Stifel | Buy → Hold |
| Dec-13-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Apr-14-23 | Initiated | Mizuho | Buy |
| Mar-29-23 | Initiated | UBS | Buy |
| Dec-13-22 | Upgrade | Goldman | Neutral → Buy |
| Dec-13-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Apr-13-22 | Initiated | Truist | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-04-21 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-15-20 | Downgrade | Goldman | Buy → Neutral |
| Nov-03-20 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-03-20 | Upgrade | Oppenheimer | Underperform → Perform |
| Sep-22-20 | Initiated | JP Morgan | Overweight |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Aug-06-20 | Downgrade | BofA Securities | Buy → Neutral |
| Jul-15-20 | Initiated | Goldman | Buy |
| Jun-18-20 | Reiterated | Piper Sandler | Overweight |
| May-18-20 | Initiated | Lake Street | Buy |
| Apr-28-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Apr-09-20 | Initiated | Piper Sandler | Overweight |
| Jan-28-20 | Initiated | Oppenheimer | Underperform |
| Jan-27-20 | Initiated | Oppenheimer | Underperform |
| Nov-06-19 | Upgrade | Berenberg | Sell → Hold |
| Feb-05-19 | Initiated | Dougherty & Company | Buy |
| Nov-28-18 | Initiated | Berenberg | Sell |
| Oct-29-18 | Initiated | Leerink Partners | Outperform |
| May-29-18 | Initiated | Guggenheim | Buy |
| May-29-18 | Initiated | Stifel | Buy |
| May-29-18 | Initiated | Wells Fargo | Outperform |
View All
Inspire Medical Systems Inc Stock (INSP) Latest News
Brown Capital Management LLC Has $20.63 Million Stake in Inspire Medical Systems, Inc. $INSP - MarketBeat
Trading the Move, Not the Narrative: (INSP) Edition - Stock Traders Daily
Inspire Lawsuit Alleges Sleep Apnea Implant Problems Concealed - AboutLawsuits.com
Federated Hermes Inc. Sells 124,528 Shares of Inspire Medical Systems, Inc. $INSP - MarketBeat
Inspire Medical Systems, Inc. (INSP) Stock Analysis: Exploring a 64.34% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Short Squeeze: Can Inspire Medical Systems Inc stock double in the next yearJuly 2025 Trade Ideas & Safe Swing Trade Setups - baoquankhu1.vn
Guidance Update: Can SNSE sustain earnings growthWeekly Risk Summary & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Trend Review: Why is Inspire Medical Systems Inc stock going downQuarterly Portfolio Report & Stepwise Swing Trade Plans - baoquankhu1.vn
Inspire Medical Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Inspire Medical Systems, Inc.INSP - Business Wire
Inspire downgraded at Oppenheimer following CMS NCD correction - MSN
Kuehn Law Encourages Investors of Inspire Medical Systems, Inc. to Contact Law Firm - marketscreener.com
Inspire Medical Leaders Face Suit Over Apnea Device Rollout - Law360
Inspire Medical Systems, Inc. $INSP Shares Sold by Kornitzer Capital Management Inc. KS - MarketBeat
Unpacking Q3 Earnings: Inspire Medical Systems (NYSE:INSP) In The Context Of Other Medical Devices & SuppliesSpecialty Stocks - Yahoo Finance
KeyCorp Has Bullish Estimate for INSP FY2025 Earnings - MarketBeat
EFG Asset Management North America Corp. Has $2.05 Million Position in Inspire Medical Systems, Inc. $INSP - MarketBeat
Forecasting The Future: 19 Analyst Projections For Inspire Medical Systems - Benzinga
Equities Analysts Issue Forecasts for INSP FY2027 Earnings - MarketBeat
A Look At Inspire Medical Systems (INSP) Valuation After CMS Reimbursement Uncertainty - simplywall.st
Y Intercept Hong Kong Ltd Grows Stock Holdings in Inspire Medical Systems, Inc. $INSP - MarketBeat
Baillie Gifford & Co. Sells 29,538 Shares of Inspire Medical Systems, Inc. $INSP - MarketBeat
Assessing Inspire Medical Systems (INSP) Valuation After A Difficult Year For Shareholder Returns - Yahoo Finance
Wells Fargo is bullish on Inspire Medical Systems, Inc. (INSP) despite short-term reimbursement concerns - MSN
Inspire Medical Systems, Inc. (NYSE:INSP) Given Average Rating of "Hold" by Brokerages - MarketBeat
Analyst Upgrade: Will ZKH Group Limited Depositary Receipt benefit from geopolitical trendsWeekly Gains Report & Community Consensus Picks - baoquankhu1.vn
Why Inspire Medical Systems (INSP) Is Down 13.9% After CFO Change And Medicare Reimbursement Uncertainty - Sahm
Inspire Medical Systems Shares Fall After Truist Downgrade - marketscreener.com
Truist Financial Maintains Inspire Medical Systems(INSP.US) With Hold Rating, Maintains Target Price $96 - 富途资讯
(INSP) Volatility Zones as Tactical Triggers - Stock Traders Daily
Inspire Medical Systems (NYSE:INSP) Shares Down 7.5% After Analyst Downgrade - MarketBeat
Inspire Medical Systems Board Under Investigation, 2025 Earnings Guidance Cut by Over 80% - Intellectia AI
The Law Offices of Frank R. Cruz Announces Investigation of Inspire Medical Systems, Inc. (INSP) on Behalf of Investors - marketscreener.com
Truist Securities downgrades Inspire Medical stock on coding setback By Investing.com - Investing.com Canada
Inspire Medical Systems (INSP) Stock Trades Down, Here Is Why - Finviz
Inspire Medical Systems (NYSE:INSP) Cut to "Hold" at Truist Financial - MarketBeat
CMS removes OSA coverage for Inspire Medical Systems reimbursement uplift - Investing.com Canada
Inspire Medical (INSP) Faces Downgrade Amid Coding Changes - GuruFocus
Inspire Medical stock tumbles after CMS removes sleep apnea coverage By Investing.com - Investing.com Canada
Here's Why You Should Retain INSP Stock in Your Portfolio for Now - Finviz
Oppenheimer downgrades Inspire Medical stock on CMS reimbursement reversal By Investing.com - Investing.com Canada
INSP Shares Drop Following CMS Correction and Analyst Downgrade - GuruFocus
Inspire Medical (INSP) Faces Medicare Reimbursement Adjustment - GuruFocus
Inspire Medical Systems (NYSE:INSP) Lowered to "Market Perform" Rating by Oppenheimer - MarketBeat
Wells Fargo Is Bullish on Inspire Medical Systems, Inc. (INSP) Despite Short-Term Reimbursement Concerns - Finviz
Aug Macro: What are Inspire Medical Systems Incs growth levers2025 Earnings Surprises & Daily Entry Point Alerts - baoquankhu1.vn
2 Reasons to Watch INSP and 1 to Stay Cautious - Yahoo Finance
Update Report: Can Inspire Medical Systems Inc sustain earnings growthJuly 2025 Highlights & AI Powered Market Entry Strategies - baoquankhu1.vn
Inspire Medical Systems, Inc. (INSP): Stock Analysis Highlights 50% Potential Upside for Investors - directorstalkinterviews.com
A Look At Inspire Medical Systems (INSP) Valuation After New Growth Guidance And CFO Appointment - Sahm
Inspire Medical Systems, Inc. (INSP): A Bull Case Theory - Finviz
Swing Trade: What is JYNTs P E ratio telling usWeekly Stock Recap & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Inspire Medical Systems Inc Stock (INSP) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.10%
0.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):